diminazene has been researched along with Neoplasms in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 1 (50.00) | 2.80 |
Authors | Studies |
---|---|
Huang, TL; Mayence, A; Vanden Eynde, JJ | 1 |
Apostolopoulos, V; Egom, EE; Gadanec, LK; Kruzliak, P; Kubatka, P; Levinger, I; McSweeney, KR; Qaradakhi, T; Rimarova, K; Rodrigo, L; Tacey, A; Zulli, A | 1 |
2 review(s) available for diminazene and Neoplasms
Article | Year |
---|---|
Some non-conventional biomolecular targets for diamidines. A short survey.
Topics: Amidines; Animals; Diabetes Mellitus, Type 2; DNA; Enzymes; Humans; Hypertension; Ion Channels; Myotonic Dystrophy; Neoplasms; Neurodegenerative Diseases; Proteins; RNA; Thrombosis | 2014 |
The potential actions of angiotensin-converting enzyme II (ACE2) activator diminazene aceturate (DIZE) in various diseases.
Topics: Angiotensin-Converting Enzyme 2; Animals; Cardiovascular Diseases; Diminazene; Enzyme Activation; Enzyme Activators; Humans; Neoplasms; Renin-Angiotensin System | 2020 |